ALX Oncology Inc.
ALXO | NASDAQ
$1.66
-$0.04 (-2.35%)
At close: Sep 21, 2026, 4:00 PM ET
$1.65
-$0.01 (-0.60%)
After-hours:
Sep 21, 2026, 7:52 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | 1.18M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | 1.08M |
Gross Profit | n/a | n/a | n/a | n/a | n/a | 107K |
Operating Income | -104.02M | -142.47M | -170.28M | -127.44M | -83.56M | -43.66M |
Interest Income | 3.96M | 9.37M | 10.65M | 4.28M | 91 | n/a |
Pretax Income | -101.7M | -134.85M | -160.81M | -123.42M | -83.48M | -45.5M |
Net Income | -101.7M | -134.85M | -160.81M | -123.48M | -83.46M | -45.74M |
Selling & General & Admin | 23.85M | 26.09M | 28.48M | 29.04M | 23.39M | 14.81M |
Research & Development | 77M | 116.37M | 141.8M | 98.4M | 60.17M | 28.96M |
Other Expenses | 3.18M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 104.02M | 142.47M | 170.28M | 127.44M | 83.56M | 43.77M |
Interest Expense | 1.6M | 1.73M | 1.57M | 238K | 13K | 811K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 104.02M | 142.47M | 170.28M | 127.44M | 83.56M | 44.85M |
Income Tax Expense | n/a | n/a | n/a | 64K | -21K | 241K |
Shares Outstanding (Basic) | 53.66M | 52.17M | 42.99M | 40.7M | 40.31M | 39.84M |
Shares Outstanding (Diluted) | 53.66M | 52.17M | 42.99M | 40.7M | 40.31M | 39.84M |
EPS (Basic) | -1.90 | -2.58 | -3.74 | -3.03 | -2.07 | -1.28 |
EPS (Diluted) | -1.90 | -2.58 | -3.74 | -3.03 | -2.07 | -1.28 |
EBITDA | -99.39M | -132.25M | -158.4M | -122.84M | -83.42M | -43.46M |
EBIT | -100.09M | -133.12M | -159.24M | -123.18M | -83.47M | -43.66M |
Depreciation & Amortization | 706K | 872K | 836K | 342K | 51K | 202K |
Add to Watchlist
Select watchlists to add or remove ALXO